BioTuesdays

Category - Markets

Palatin Technologies Logo
Markets

Roth resumes coverage of Palatin, AmpliPhi, Pharming

Roth Capital Partners resumed coverage of Palatin Technologies (NYSE MKT: PTN), AmpliPhi Biosciences (NYSE MKT:APHB) and Pharming Group NV (OTC:PHGUF) with “buy” ratings and price targets of $1.50, $3 and €1.50...

January 24, 2017
Bellerophon Therapeutics
Markets

HCW starts Bellerophon Therapeutics at buy

H.C. Wainwright initiated coverage of Bellerophon Therapeutics (NASDAQ:BLPH) with a “buy” rating and price target of $5. The stock closed at 67 cents on Jan. 20. Bellerophon develops products for the treatment of...

January 23, 2017
Trevena
Markets

HCW starts Trevena at buy

H.C. Wainwright initiated coverage of Trevena (NASDAQ:TRVN) with a “buy” rating and $11 price target. The shares were changing hands at $6.85 at mid-day on Jan. 9. “We believe Trevena’s lead drug, oliceridine...

January 9, 2017
Natera
Markets

Canaccord starts Natera at buy

Canaccord Genuity initiated coverage of Natera (NASDAQ:NTRA) with a “buy” rating and $18 price target. The stock is changing hands at $11.66 in afternoon trading on Jan. 6. Natera is the market leader in the $2.5...

January 6, 2017
Calithera Biosciences
Markets

HCW starts Calithera Biosciences at buy

H.C. Wainwright initiated coverage of Calithera Biosciences (NASDAQ:CALA) with a “buy” rating and $9 price target. The stock closed at $3.95 on Jan. 5. Calithera is developing oral drugs that target feeding of cancer...

January 6, 2017
Achaogen
Markets

Leerink starts Achaogen at outperform

Leerink initiated coverage of Achaogen (NASDAQ:AKAO) with an “outperform” rating and $21 price target. The shares were changing hands at $13.90 in afternoon trading on Jan. 4. Achaogen is developing lead product...

January 4, 2017
Codexis
Markets

Ladenburg upgrades Codexis to buy

Ladenburg Thalmann upgraded Codexis (NASDAQ:CDXS) to “buy” from “neutral” with a new price target of $6.25. The shares were quoted at $4.65 in afternoon trading on Jan. 4. Analyst Kevin DeGeeter cited growing confidence...

January 4, 2017
3D Signatures
Markets

3DS begins trading on OTCQB and FSE

Common shares of 3D Signatures (TSX-V:DXD) have started trading on the OTCQB Venture Market in the U.S. under the symbol, TDSGF, and on the Frankfurt Stock Exchange (FSE) in Germany under the symbol, 3D0. 3D Signatures...

January 4, 2017
Intra Cellular Therapies
Markets

BTIG starts Intra-Cellular Therapies at buy

BTIG launched coverage of Intra-Cellular Therapies (NASDAQ:ITCI) with a “buy” rating and $44 price target, saying there is considerable promise for the company’s antipsychotic, ITI-007, in multiple indications. The...

December 22, 2016
Catabasis Pharma
Markets

HCW starts Catabasis Pharma at buy

H.C. Wainwright initiated coverage of Catabasis Pharmaceuticals (NASDAQ:CATB) with a “buy” rating and $14 price target. The stock closed at $3.59 on Dec. 21. “The SMART Linker technology is key to our investment...

December 22, 2016